Updates on managing Myleodysplastic Syndromes

This is a very scientific entry at Cancer Consultants.com.  But if you want to research Myleodysplastic Syndromes, then here is some information.

Here's the introduction:

The myelodysplastic syndromes (MDS) are a collection of clonally-derived hematopoietic disorders typified by peripheral blood cytopenias, transfusion-dependency, and in a subset of patients, increased likelihood of transformation to acute myeloid leukemia (AML).1,2 This past decade has brought increased attention to MDS with the approval by the U.S. Food and Drug Administration of three MDS therapies, and a more complete understanding of these diseases on a molecular level. This year at the American Society of Hematology (ASH) 2007 annual meeting, presentations focused on the implications and management of MDS- and treatment-related cytopenias; results of clinical trials of hypomethylating agents, including the first prospectively-acquired survival data; and extension of the potential applicability of immunomodulatory drugs.


Source:  CancerConsultants.com

Benzene and Gas Fumes: A story

Here is a story abotu a man who fought the workers compensation system in Wyoming to get coverage for his Myelodysplastic Anemia.

But something else was happening to Burgess's body, inside his bones. He was suffering severe headaches, and his blood was high in iron. He sought a diagnosis in 2000. A core sample of his hip bone confirmed he suffered from myelodysplastic anemia -- bone cancer.

Even with health insurance, the family still had to come up with $45,000 before the Cancer Care Alliance at the University of Washington could take him as a patient. The Burgess family relied on credit cards as they scrambled to prepare for his bone marrow transplant.

In April 2001, Burgess quit his job at Farmers' Co-op and flew with his daughter the next day to Seattle for his transplant.

The transplant was a success, but the family's struggles were far from over. Friends and co-workers held a benefit to raise money, and the Burgesses were overwhelmed by the support they received.

But by the time the family came home from Seattle, there was no money left.

"I didn't know where the next dime was coming from," said Burgess's wife, Val. "We had to fight the system."

Burgess's condition wasn't considered work-related.

He had spent some 15 years driving a fuel truck at Farmers' Co-op. Hair follicle samples indicated a high level of benzene in Burgess's body. The family believed that he had adsorbed and retained benzenes from frequent exposure to gasoline fumes without a respirator.

The workers' compensation division denied the claim, according to the family. Val sought an attorney and soon discovered that lawyers in Wyoming were reluctant to take on the workers' compensation program. She said one attorney in Casper told her outright that if they took on workers' compensation, "You're going to lose."

Val continued to fight. She eventually found a law firm in Pennsylvania that specialized in benzene cases. The family took the workers' compensation program to court, and they settled.

After that, workers' compensation began reimbursing medical expenses and travel for follow-up treatments. The Burgesses were relieved and grateful for the help, but working with the workers' compensation program proved difficult.

Val said it seemed like the program was designed to discourage people from getting help, and denying claims seemed habitual.

Burgess had developed high blood pressure as a result of photopheresis treatment. But workers' compensation officials initially refused to pay, despite several letters from doctors explaining it was symptomatic of Burgess's continued medical needs.

Val said that's the type of rigamarole the family experienced with workers' compensation over and over.

"It's a tough thing," she said. "I know you can't give everybody everything. But workers' compensation counts on people giving up."

Source:  Jackson Hole Star Tribune Myelodysplastic Syndromes

MyleoDysplactic Syndromes Lawsuit

Printers are one group of people who have historically had some significant benzene exposure.  Here is an example of a lawsuit filed in Illinois claiming that benzene exposure caused myleodysplastic syndromes.

The estate of James Granat filed suit against 19 defendant corporations in Madison County Circuit Court claiming his benzene exposure caused him to develop myelodysplastic syndrome and acute myelogenous leukemia which led to his death on Jan 17.

According to the complaint filed March 5, Granat worked for various employers throughout Illinois performing work in the printing industry and as a security guard.

The suit claims Granat's exposure to benzene was completely foreseeable and could or should have been anticipated by the defendants. It also claims the defendants knew or should have known that benzene had a toxic, poisonous and highly deleterious effect upon the health of the persons inhaling, ingesting or otherwise absorbing it.

The eight-count suit seeks in excess of $400,000 in compensatory damages and attorney fees.

Benzene is an aromatic hydrocarbon that is produced by the burning of natural products. It is a component of products derived from coal and petroleum and is found in gasoline and other fuels and is used to make some types of rubbers, lubricants, dyes, detergents, drugs and pesticides.

Natural sources of benzene include volcanoes and forest fires. Benzene also is a natural part of crude oil, gasoline, and cigarette smoke.

Benzene, which is known to be a carcinogen, is used in the manufacture of plastics, detergents, pesticides and other chemicals.

Source:  Madison County Record

Cheek Swabs to Find Bone Marrow donors

If you make it easy then maybe people will be more likely to step up and help.  Looks like that strategy worked here.  Cheek swabs to find donors is a much less invasive method of finding a bone marrow match than a blood draw.

A B.C. pilot project using free, Web mail-order cheek swab kits to recruit young and ethnically diverse bone marrow stem cell donors, is being deemed such a whopping success that it's now being rolled out across the country.

Ethnic groups are being targeted because 85 per cent of would-be donors in the bone marrow registry are Caucasian, which makes it highly difficult to find matches for ethnic patients. Younger donors are sought because they are the healthiest.

The national program follows a Canadian Blood Services (CBS) project over the past four months in B.C., during which cheek swab kits were mailed to those between the ages of 17 and 50 after they registered for them online.

The kits contain long sticks resembling Q-tips to scrape skin cells from the inside of cheeks. The kit is sent back to CBS in Ottawa; the individual's DNA is then extracted, typed and entered in a database.

Before the cheek swab kits were introduced, would-be donors had to go to a laboratory for a blood draw, a far more expensive, inconvenient process. Now the cheek swab kits will largely replace laboratory blood collection for DNA typing.

Source:  Canada.com

MDS: Is it cancer, pre-cancer or non-of the above

I found this interesting blog post on Myelodysplastic Syndromes.  It discusses whether MDS will always lead to cancer.  It has a lot of good information.

Primary MDS represents a family of diseases, most prevalent in those over the age of 50 to 60, that involve unwanted variations in the function of the bone marrow in its role as the storehouse and processing center of the stem cells that ultimately turn into blood cells. These MD syndromes are called primary because they do not develop after a patients has been treated aggressively for cancer by radiation or chemotherapy which are known to cause MDS as a secondary, or side-effect. Nor do primary MDS patients have a known long-term exposure to hematologically carcinogenic chemicals like benzene, which can bring on MDS and leukemia.

Source:  http://sla-divisions.typepad.com/dbio/2008/01/the-myelodyspla.html